{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:25:28Z","timestamp":1790673928487,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Since sodium valproate, a commonly used antiepileptic drug, has been reported to be unstable in the presence of moisture, our objective was to investigate the effect of repackaging into dose administration aids.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Sodium valproate 100 mg immediate-release tablets were repackaged and stored for 56 days at accelerated conditions (40\u00b0C\/75% relative humidity), room temperature (25\u00b0C) and under refrigeration (2\u20138\u00b0C). Samples were analysed at 3, 7, 10, 14, 21, 35, 49 and 56 days to determine chemical stability using high-performance liquid chromatography, while physical testing included assessment of weight changes and dissolution behaviour.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The results revealed that the sodium valproate content in the tablets remained within the acceptable range of 90\u2013110% under all storage conditions for 56 days. Physical stability, however, was not maintained, with a total weight gain of 12.36% under accelerated conditions over the 56 days. Samples stored under all conditions showed variable dissolution compared to the controls, with the amount of sodium valproate in solution following 45 min of dissolution testing below 75% for half of all the intervals determined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Repackaging sodium valproate tablets into dose administration aids results in unacceptable weight variation and changes in the dissolution profiles.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1211\/jpp.62.07.0004","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T20:54:24Z","timestamp":1441313664000},"page":"838-843","source":"Crossref","is-referenced-by-count":22,"title":["Stability of sodium valproate tablets repackaged into dose administration aids"],"prefix":"10.1093","volume":"62","author":[{"given":"Victoria K","family":"Llewelyn","sequence":"first","affiliation":[{"name":"School of Pharmacy and Molecular Sciences, James Cook University , Townsville,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina F","family":"Mangan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Molecular Sciences, James Cook University , Townsville,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley D","family":"Glass","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Molecular Sciences, James Cook University , Townsville,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"2024103013100253400_cit1","volume-title":"Dose administration aids","author":"School of Pharmacy and Medical Sciences, University of South Australia","year":"1997"},{"key":"2024103013100253400_cit2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/157488609787354459","article-title":"Compliance aids and medicine stability: new evidence of quality assurance","volume":"4","author":"Glass","year":"2009","journal-title":"Curr Drug Saf"},{"key":"2024103013100253400_cit3","first-page":"75","article-title":"How stable are medicines moved from original packs into compliance aids?","volume":"276","author":"Church","year":"2006","journal-title":"Pharm J"},{"key":"2024103013100253400_cit4","first-page":"60","article-title":"Pilot study of the short-term physico-chemical stability of atenolol tablets stored in a multi-compartment compliance aid","volume":"13","author":"Chan","year":"2007","journal-title":"Eur J Hosp Pharm Sci"},{"key":"2024103013100253400_cit5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/j.2055-2335.2006.tb00881.x","article-title":"Stability implications of repackaging paracetamol tablets into dose administration aids","volume":"36","author":"Haywood","year":"2006","journal-title":"J Pharm Prac Res"},{"key":"2024103013100253400_cit6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/j.2055-2335.2007.tb00738.x","article-title":"Stability of frusemide tablets repackaged in dose administration aids","volume":"37","author":"Bowen","year":"2007","journal-title":"J Pharm Prac Res"},{"key":"2024103013100253400_cit7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2710.2008.00981.x","article-title":"Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality?","volume":"34","author":"Glass","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"2024103013100253400_cit8","volume-title":"Guidelines and standards for pharmacists \u2013 Dose administration aids service","author":"Pharmaceutical Society of Australia","year":"2007"},{"key":"2024103013100253400_cit9","volume-title":"Repackaging into Single-unit Containers and Unit-dose Containers for Nonsterile Solid and Liquid Dosage Forms","author":"USP32\/NF27 681","year":"2009"},{"key":"2024103013100253400_cit10","volume-title":"Medicines, Ethics, and Practice: a Guide for Pharmacists","author":"Royal Pharmaceutical Society of Great Britain","year":"2003"},{"issue":"Suppl. 2","key":"2024103013100253400_cit11","first-page":"5","article-title":"The history of valproate in clinical neuroscience","volume":"37","author":"Henry","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"2024103013100253400_cit12","first-page":"529","article-title":"Sodium valproate and valproic acid","volume-title":"Analytical Profiles of Drug Substances","author":"Chang","year":"1979","edition":"8th"},{"key":"2024103013100253400_cit13","volume-title":"United States Pharmacopoeia 25th edn\/National Formulary","author":"The United States Pharmacopeial Convention","year":"2002","edition":"20th"},{"key":"2024103013100253400_cit14","volume-title":"Stability data package for registration applications in climatic zones III and IV: Note for guidance on stability datapackage for registration in climatic zones III and IV","author":"ICH Q1F","year":"2003"},{"key":"2024103013100253400_cit15","first-page":"107","volume-title":"EU guideline \u2013 As adopted in Australia by the TGA \u2013 with amendment: Validation of analytical procedures: Methodology","author":"Therapeutic Goods Administration","year":"2002"},{"key":"2024103013100253400_cit16","volume-title":"British Pharmacopoeia","year":"2007"},{"key":"2024103013100253400_cit17","volume-title":"Analysis of basic drugs in postmortem blood by HPLC with diode array detection: Varian Application Note #12","author":"Davies"},{"key":"2024103013100253400_cit18","volume-title":"Epilim\u00ae Product Information","author":"Sanofi-Synthelabo Australia Pty Ltd","year":"2007"},{"key":"2024103013100253400_cit19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/cpt1977216736","article-title":"Pharmacokinetics and bioavailability of sodium valproate","volume":"21","author":"Klotz","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"2024103013100253400_cit20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1059-1311(96)80013-6","article-title":"Generic prescribing for epilepsy. Is it safe?","volume":"5","author":"Crawford","year":"1996","journal-title":"Seizure"},{"key":"2024103013100253400_cit21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.seizure.2005.12.010","article-title":"Are there potential problems with generic substitution of antiepileptic drugs? A review of issues","volume":"15","author":"Crawford","year":"2006","journal-title":"Seizure"},{"key":"2024103013100253400_cit22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1528-1157.1993.tb02140.x","article-title":"Reduced bioavailability of moisture-exposed carbamazepine resulting in status epilepticus","volume":"34","author":"Bell","year":"1993","journal-title":"Epilepsia"},{"key":"2024103013100253400_cit23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ana.410070218","article-title":"Reduced seizure control due to spoiled phenytoin capsules","volume":"7","author":"Cloyd","year":"1980","journal-title":"Ann Neurol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/7\/838\/60233307\/jpp.62.07.0004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/7\/838\/60233307\/jpp.62.07.0004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:42:16Z","timestamp":1730313736000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/62\/7\/838\/6135596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7,1]]},"published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.62.07.0004","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,7]]},"published":{"date-parts":[[2010,7,1]]}}}